Semaglutide® $399/ Month
Tirzepatide® $599/ Month

Our Medical Weight Loss programs support you through your Wellness & Weight Loss journey. Weekly injections paired with 4 Vitamin injections, support your nutritional status as your body undergoes changes while on Semaglutide® or Tirzepatide®. These FDA approved weight loss medications known as glucagon-like peptide-1, or GLP-1. The primary role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose). Known benefits of decreased appetize and cravings with reduction in overall body fat percentage Semaglutide® or Tirzepatide® will be administered by our nurses once weekly.

*Monthly Packages*
3 Month (1-3) = $999 Every Month you will receive 4 Vitamin injections in addition to your Semaglutide® injection.
3 Month (4-6) = $1299 Every Month you will receive 4 Vitamin injections in addition to your Semaglutide® injection.
3 Month (1-3) = $1599 Every Month you will receive 4 Vitamin injections in addition to your Tirzepatide® injection.
3 Month (4-6) = $1899 Every Month you will receive 4 Vitamin injections in addition to your Tirzepatide® injection.

FAQ's Semaglutide® & Tirzepatide® (GLP-1)

What does an GLP-1 do in the body? They mimic the action of the hormone called glucagon-like peptide 1 GLP-1). When blood sugar levels start to rise after someone eats, these drugs stimulate the body to produce more insulin. The extra insulin helps lower blood sugar levels, which are helpful in controlling Type II Diabetes.

How do I take this medication? You will have weekly nurse visits in our clinic where you’ll receive a very small injection into your abdomen area, most say they cannot feel the injection. The injection will be administered by a Registered Nurse and is a short visits are your initial consultation.

What kind of foods should I eat while taking an GLP-1? Nutrition Best Practices are eating enough food from lean protein sources. Think about foods like chicken, fish, eggs, plant-based foods like tofu or edamame, and low-fat dairy foods like milk, protein drinks, greek yogurt, and cottage cheese. Lean cuts of red meat and pork are good choices too, just a little less often! During your weekly nurse visits you’ll discuss and review how your week has been with eating and exercise as you progress through our program.

Who are these medications for?      
Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present.  
Weight loss - GLP-1 agonists could also be     considered for weight loss even in the absence of type 2 diabetes.     Suggested cut-off is BMI >30, or >27 with weight related co-morbidity. 

What are the side effects of a GLP-1 medication? While common side effects often improve over time some experience nausea, vomiting and/or diarrhea. The side effects occur as your body adjusts to the process your body undergoes while taking anGLP-1, this is why your food intake is extremely important and why we also administer vitamin injections to ensure your maintaining essential vitamins and minerals.

Will I gain weight after I stop taking the GLP-1? This is one of the biggest questions we get! There is a very high chance that individuals will gain their weight back if they stop taking their prescribed GLP-1 which is why we have additional support here at our clinic to assist with this. Our maintenance program has a natural supplement that takes sugar and converts it to fiber. After ideal wight is reached we start our clients on this extremely affordable supplement for our maintenance program.

Who should not take a GLP-1? This is not recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia. Lab studies have linked these drugs with thyroid tumors in rats. But until more long-term studies are done, the risk to humans isn't known. They're also not recommended if you've had pancreatitis.  

American Diabetes Association. Standards of medical care in diabetes — 2020. Diabetes Care. 2020;     doi:10.2337/dc20-SINT.
Dungan K, et al. Glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus. Accessed April 10, 2020.
Goldman L, et al., eds. Diabetes     mellitus. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. Accessed April 11, 2020.
Hu M, et al. Effect of hemoglobin A1c reduction or weight reduction on blood pressure in glucagon-like     peptide-1receptor agonist and sodium-glucose cotransporter-2 inhibitor     treatment in type 2 diabetes mellitus: A meta-analysis. Journal of the     American Heart Association. 2020; doi:10.1161/JAHA.119.015323.
Boyle JG, et al. Cardiovascular     benefits of GLP-1 agonists in type 2 diabetes: A comparative review.     Clinical Science. 2018; doi:10.1042/CS20171299.
Bellastella G, et al.     Glucagon-like peptide-1 receptor agonists and prevention of stroke     systematic review of cardiovascular outcome trials with meta-analysis.     Stroke. 2020; doi:10.1161/STROKEAHA.119.027557.
Perreault L. Obesity in adults:     Drug therapy. Accessed May 13,     2022.